A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC
ANNÉE
2024
AUTEURS
Ducreux MP, Ben Abdelghani M, Tougeron D, Bouche O, Viaud J, Khemissa Akouz F, Martin-Babau JF, Bachet JB, Coutzac C, Castanie H, Taieb J, Phelip JM, Fares N, Etchepare N, Botsen D , Mailleux N, Chevrot M,TANGUY , Parzy A
CONGRÈS/REVUE
ESMO GI
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES